In conversation with... Carlos Fernández de Larrea and Damian Green

from Listen to The Lancet Oncology · host The Lancet

Carlos Fernández de Larrea (Hospital Clínic de Barcelona, Barcelona, Spain) and Damian Green (Fred Hutch Cancer Center, Seattle, WA, USA) discuss their studies on BCMA CAR T cells in patients with relapsed or refractory multiple myeloma.

Episode metadata supplied by the publisher feed · Published Jul 3, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

In conversation with... Carlos Fernández de Larrea and Damian Green

0:00 33:50

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Listen to The Lancet Oncology?

This episode is 33 minutes long.

When was this Listen to The Lancet Oncology episode published?

This episode was published on July 3, 2023.

Can I download this Listen to The Lancet Oncology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!